New Germany Fund (GF) 15.57 $GF Closed-End Funds

New Post Public Reply Private Reply Replies (0) Message Board

Mar 22, 2015 at 12:41 AM

New Germany Fund (GF) 15.57 $GF

Closed-End Funds Strategies For 2014 And 2015: CEFs For Buying And Selling
Joe Eqcome - Seeking Alpha - Wed Jan 14, 5:34PM CST
Losses to Stars: Over the years, the poorest performing closed-end funds (NYSEMKT: CEF ) at the end of the year often turned around and became the "stars" of the new-year. (In 2013, GenEqFnds was in 1st place; SingleStMuniFnds and ...
MXF: 21.95 (+0.39), CFP: 15.83 (+0.05), IIF: 28.59 (+0.36), GF: 15.57 (+0.32), TTF: 8.82 (+0.05), UTG: 30.23 (+0.24), CEE: 20.35 (+0.67), RIT: 13.26 (+0.19), IFN: 28.70 (+0.27), EVN: 13.48 (+0.15), RQI: 12.59 (+0.20), TRF: 9.73 (+0.19)

The Central Europe, Russia and Turkey Fund, Inc., The New Germany Fund, Inc., and The European Equity Fund, Inc. Make Yearly Distribution Announcements
Business Wire - Fri Dec 19, 4:00PM CST
The Central Europe, Russia and Turkey Fund, Inc. (NYSE:CEE) and The New Germany Fund, Inc. (NYSE:GF) (each, a "Fund," and collectively, the "Funds"

each announced today that its Board of Directors declared the distributions set forth below. Each Fund's total distributions will be paid in stock except that any stockholder of record as of December 31, 2014 may elect to receive such distribution in cash.
GER: 14.24 (+0.07), GF: 15.57 (+0.32), CEE: 20.35 (+0.67), EEA: 8.78 (+0.11)

The European Equity Fund, Inc. and The New Germany Fund, Inc. Announce Results of Tender Offer Measurement Period
Business Wire - Mon Dec 15, 4:00PM CST
The European Equity Fund, Inc. (NYSE:EEA) and The New Germany Fund, Inc. (NYSE:GF) (each, a "Fund," and collectively, the "Funds"

announced today the results of a fifteen-week measurement period that began on Tuesday, September 2, 2014 and expired on Friday, December 12, 2014, in accordance with each Fund's previously announced Discount Management Program (the "Program"

. At the conclusion of the measurement period, shares of common stock of EEA had traded at an average discount to NAV of -10.93% and shares of common stock of GF had traded at an average discount to NAV of -8.99%, in each case during the fifteen-week measurement period. The terms of the Program require a Fund to conduct a tender offer if its shares trade at an average discount to NAV of more than 10% during the applicable fifteen-week measurement period. Therefore, EEA will conduct its tender offer for up to 5% of its outstanding shares at a price equal to 98% of NAV, but GF will not conduct a tender offer. Details concerning the tender offer for EEA will be announced in the upcoming weeks.
GF: 15.57 (+0.32), EEA: 8.78 (+0.11)

Webcast Conference on The Central Europe, Russia and Turkey Fund (CEE), The European Equity Fund (EEA), and The New Germany Fund (GF)
Marketwired - Thu Nov 13, 11:59AM CST
The Germany Funds are pleased to announce a webcast conference "Review and Outlook," taking place on Wednesday, November 19, 2014 at 11:00 a.m. (ET).
GF: 15.57 (+0.32), CEE: 20.35 (+0.67), EEA: 8.78 (+0.11)

15.9% Return Seen to Date on SmarTrend New Germany Fund Call (GF)
Comtex SmarTrend(R) - Tue Nov 11, 11:07AM CST
SmarTrend identified a Downtrend for New Germany Fund (NYSE:GF) on December 27th, 2013 at $19.85. In approximately 11 months, New Germany Fund has returned 15.87% as of today's recent price of $16.70.
GF: 15.57 (+0.32)

Shares of GF Down 17.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Nov 04, 9:48AM CST
SmarTrend identified a Downtrend for New Germany Fund (NYSE:GF) on December 27th, 2013 at $19.85. In approximately 10 months, New Germany Fund has returned 17.08% as of today's recent price of $16.46.
GF: 15.57 (+0.32)

New Germany Fund Down 17.3% Since SmarTrend Downtrend Call (GF)
Comtex SmarTrend(R) - Tue Oct 28, 9:16AM CDT
SmarTrend identified a Downtrend for New Germany Fund (NYSE:GF) on December 27th, 2013 at $19.85. In approximately 10 months, New Germany Fund has returned 17.28% as of today's recent price of $16.42.
GF: 15.57 (+0.32)

New Germany Fund Has Returned 20.9% Since SmarTrend Recommendation (GF)
Comtex SmarTrend(R) - Mon Oct 20, 5:00PM CDT
SmarTrend identified a Downtrend for New Germany Fund (NYSE:GF) on December 27th, 2013 at $19.85. In approximately 10 months, New Germany Fund has returned 20.86% as of today's recent price of $15.71.
GF: 15.57 (+0.32)

21.4% Return Seen to Date on SmarTrend New Germany Fund Call (GF)
Comtex SmarTrend(R) - Mon Oct 13, 11:03AM CDT
SmarTrend identified a Downtrend for New Germany Fund (NYSE:GF) on December 27th, 2013 at $19.85. In approximately 10 months, New Germany Fund has returned 21.36% as of today's recent price of $15.61.
GF: 15.57 (+0.32)

New Germany Fund Shares Down 17.0% Since SmarTrend's Sell Call (GF)
Comtex SmarTrend(R) - Mon Oct 06, 9:55AM CDT
SmarTrend identified a Downtrend for New Germany Fund (NYSE:GF) on December 27th, 2013 at $19.85. In approximately 9 months, New Germany Fund has returned 17.03% as of today's recent price of $16.47.
GF: 15.57 (+0.32)

Downtrend Call Working As New Germany Fund Stock Falls 11.7% (GF)
Comtex SmarTrend(R) - Fri Sep 19, 5:06PM CDT
SmarTrend identified a Downtrend for New Germany Fund (NYSE:GF) on December 27th, 2013 at $19.85. In approximately 9 months, New Germany Fund has returned 11.69% as of today's recent price of $17.53.
GF: 15.57 (+0.32)

New Germany Fund Has Returned 11.3% Since SmarTrend Recommendation (GF)
Comtex SmarTrend(R) - Thu Aug 21, 11:12AM CDT
SmarTrend identified a Downtrend for New Germany Fund (NYSE:GF) on December 27th, 2013 at $19.85. In approximately 8 months, New Germany Fund has returned 11.31% as of today's recent price of $17.60.
GF: 15.57 (+0.32)

The Central Europe, Russia and Turkey Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Extension of Share Repurchases and Adoption of New Discount Management Programs
Business Wire - Mon Jul 28, 4:00PM CDT
The Central Europe, Russia and Turkey Fund, Inc. (NYSE:CEE), The European Equity Fund, Inc. (NYSE:EEA), and The New Germany Fund, Inc. (NYSE:GF) (each, a "Fund," and collectively, the "Funds"

each announced today that its Board of Directors has approved an extension of the current repurchase authorization permitting EEA, GF and CEE to repurchase up to 950,000, 1,550,000 and 1,010,000 shares, respectively, during the period from August 1, 2014 through July 31, 2015. Repurchases will be made from time to time when they are believed to be in the best interests of a Fund.
GF: 15.57 (+0.32), CEE: 20.35 (+0.67), EEA: 8.78 (+0.11)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...